Vetpharm SRL
Vetpharm reported total assets of €5.57m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026).
The score of Vetpharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +57 % Total assets +33 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vetpharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 22 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
Vetpharm's financial analysis
- Solvency16.8%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vetpharm
Vetpharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0839.331.991
- VAT number
- BE0839331991
- Peppol
- Registered · 0208:0839331991 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Aug 2011
- Registered office
- 8870 Izegem
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Vetpharm (SRL) has been based in Izegem since 2011, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 31,770 € and equity of 937,060 €; its revenue is not published. Its solvency stands at 16.8%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vetpharm
Companies in the same business, of comparable size and area, outside its group.
- MVS in Motion Wholesale of pharmaceutical and medical goods Roeselare · balance sheet €3.93m
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Dürr Dental Benelux Wholesale of pharmaceutical and medical goods Mechelen · balance sheet €5.54m
Frequently asked questions about Vetpharm
What is the revenue of Vetpharm?
Vetpharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vetpharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0839331991 for Vetpharm, if the company is VAT-registered. Its company number (CBE) is 0839.331.991.
Where is the registered office of Vetpharm?
According to the CBE register, the registered office of Vetpharm is in 8870 Izegem.
What is the equity of Vetpharm?
At the close of the 2025 financial year, the equity of Vetpharm amounts to 937,060 €, a solvency of 16.8% of total assets.
Who manages Vetpharm?
The register lists 2 active mandates at Vetpharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vetpharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →